Protein targets of oxidized phospholipids in endothelial cells

Journal of Lipid Research

Volumn 49, Issue 3, 2008, Pages 510-520

  Gugiu, B Gabriel ^a   Mouillesseaux, Kevin ^a   Duong, Victoria ^b   Herzog, Tabitha ^b   Hekimian, Avetis ^b   Koroniak, Lukasz ^b   Vondriska, Thomas M ^b   Watson, Andrew D ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Atherosclerosis; Biotinylation; Inflammation; Interleukin 8; Lipid peroxidation; Lipoproteins; Mass spectrometry; Monocyte chemoattractant protein 1

Indexed keywords

1 PALMITOYL 2 ARACHIDONOYL SN GLYCERO 3 PHOSPHATIDYL (N BIOTINYLETHANOLAMINE); ACTIVATING TRANSCRIPTION FACTOR 3; CELL PROTEIN; HEME OXYGENASE 1; INTERLEUKIN 8; LOW DENSITY LIPOPROTEIN RECEPTOR; MESSENGER RNA; OXIDIZED LOW DENSITY LIPOPROTEIN; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; STREPTAVIDIN; UNCLASSIFIED DRUG; OXIDIZED L ALPHA 1 PALMITOYL 2 ARACHIDONOYL SN GLYCERO 3 PHOSPHORYLCHOLINE; OXIDIZED-L-ALPHA-1-PALMITOYL-2-ARACHIDONOYL-SN-GLYCERO-3-PHOSPHORYLCHOLINE; PROTEIN;

AORTA; APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; INFLAMMATION; OXIDATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN SYNTHESIS; PROTEIN TARGETING; WESTERN BLOTTING; BIOTINYLATION; CELL CULTURE; CHEMISTRY; CYTOLOGY; LIPID PEROXIDATION; METABOLISM; PROTEIN BINDING; VASCULAR ENDOTHELIUM;

ATHEROSCLEROSIS; BIOTINYLATION; CELLS, CULTURED; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; INFLAMMATION; LIPID PEROXIDATION; PHOSPHATIDYLCHOLINES; PHOSPHOLIPIDS; PROTEIN BINDING; PROTEINS;

EID: 42949121739     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M700264-JLR200     Document Type: Article

References (47)

1. Rosamond, W., K. Flegal, G. Friday, K. Furie, A. Go, K. Greenlund, N. Haase, M. Ho, V. Howard, B. Kissela, et al. for the American Heart Association Statistics Committee and Stroke Statistics. 2007. Heart Disease and Stroke Statistics - 2007 Update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 115: e69-e171.
2. Stocker, R., and J. F. Keaney, Jr. 2004. Role of oxidative modifications in atherosclerosis. Physiol. Rev. 84: 1381-1478.
3. Ross, R. 1995. Cell biology of atherosclerosis. Annu. Rev. Physiol. 57: 791-804.
4. Chisolm, G. M., and D. Steinberg. 2000. The oxidative modification hypothesis of atherogenesis: an overview. Free Radic. Biol. Med. 28: 1815-1826.
5. Bobryshev, Y. V. 2006. Monocyte recruitment and foam cell formation in atherosclerosis. Micron. 37: 208-222.
6. Skalen, K., M. Gustafsson, E. K. Rydberg, L. M. Hulten, O. Wiklund, T. L. Innerarity, and J. Boren. 2002. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature. 417: 750-754.
7. Spiteller, G. 2006. Peroxyl radicals: inductors of neurodegenerative and other inflammatory diseases. Their origin and how they transform cholesterol, phospholipids, plasmalogens, polyunsaturated fatty acids, sugars, and proteins into deleterious products. Free Radic. Biol. Med. 41: 362-387.
8. Halliwell, B. 2000. Lipid peroxidation, antioxidants and cardiovascular disease: how should we move forward? Cardiovasc. Res. 47: 410-418.
9. Imig, J. D. 2000. Eicosanoid regulation of the renal vasculature. Am. J. Physiol. Renal Physiol. 279: F965-F981.
10. Yin, H., and N. A. Porter. 2005. New insights regarding the autoxidation of polyunsaturated fatty acids. Antioxid. Redox Signal. 7: 170-184.
11. Anggard, E., and B. Samuelsson. 1965. Biosynthesis of prostaglandins from arachidonic acid in guinea pig lung. Prostaglandins and related factors. 38. J. Biol. Chem. 240: 3518-3521.
12. Hammarstrom, S. 1983. Leukotrienes. Annu. Rev. Biochem. 52: 355-377.
13. Samuelsson, B., S-E. Dahlen, J. Lindgren, C. A. Rouzer, and C. N. Serhan. 1987. Leukotrienes and lipoxins: structure, biosynthesis, and biological effects. Science. 237: 1171-1176.
14. Halliwell, B. 1989. Free radicals, reactive oxygen species and human disease: a critical evaluation with special reference to atherosclerosis. Br. J. Exp. Pathol. 70: 737-757.
15. Leitinger, N. 2003. Oxidized phospholipids as modulators of inflammation in atherosclerosis. Curr. Opin. Lipidol. 14: 421-430.
16. Berliner, J. A., and A. D. Watson. 2005. A role for oxidized phospholipids in atherosclerosis. N. Engl. J. Med. 353: 9-11.
17. Watson, A. D., N. Leitinger, M. Navab, K. F. Faull, S. Horkko, J. L. Witztum, W. Palinski, D. Schwenke, R. G. Salomon, W. Sha, et al. 1997. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo. J. Biol. Chem. 272: 13597-13607.
18. Colles, S. M., J. M. Maxson, S. G. Carlson, and G. M. Chisolm. 2001. Oxidized LDL-induced injury and apoptosis in atherosclerosis: potential roles for oxysterols. Trends Cardiovasc. Med. 11: 131-138.
19. West, J. D., and L. J. Marnett. 2006. Endogenous reactive intermediates as modulators of cell signaling and cell death. Chem. Res. Toxicol. 19: 173-194.
20. Berliner, J. A., M. C. Territo, A. Sevanian, S. Ramin, J. A. Kim, B. Bamshad, M. Esterson, and A. M. Fogelman. 1990. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J. Clin. Invest. 85: 1260-1266.
21. Cushing, S. D., J. A. Berliner, A. J. Valente, M. C. Territo, M. Navab, F. Parhami, R. Gerrity, C. J. Schwartz, and A. M. Fogelman. 1990. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc. Natl. Acad. Sci. USA. 87: 5134-5138.
22. Shih, P. T., M. J. Elices, Z. T. Fang, T. P. Ugarova, D. Strahl, M. C. Territo, J. S. Frank, N. L. Kovach, C. Cabanas, J. A. Berliner, et al. 1999. Minimally modified low-density lipoprotein induces monocyte adhesion to endothelial connecting segment-1 by activating β1 integrin. J. Clin. Invest. 103: 613-625.
23. Watson, A. D., G. Subbanagounder, D. S. Welsbie, K. F. Faull, M. Navab, M. E. Jung, A. M. Fogelman, and J. A. Berliner. 1999. Structural identification of a novel pro-inflammatory epoxyisoprostane phospholipid in mildly oxidized low density lipoprotein. J. Biol. Chem. 274: 24787-24798.
24. Subbanagounder, G., N. Leitinger, D. C. Schwenke, J. W. Wong, H. Lee, C. Rizza, A. D. Watson, K. F. Faull, A. M. Fogelman, and J. A. Berliner. 2000. Determinants of bioactivity of oxidized phospholipids: specific oxidized fatty acyl groups at the sn-2 position. Arterioscler. Thromb. Vasc. Biol. 20: 2248-2254.
25. Yeh, M., N. M. Gharavi, J. Choi, X. Hsieh, E. Reed, K. P. Mouillesseaux, A. L. Cole, S. T. Reddy, and J. A. Berliner. 2004. Oxidized phospholipids increase interleukin 8 (IL-8) synthesis by activation of the c-src/signal transducers and activators of transcription (STAT)3 pathway. J. Biol. Chem. 279: 30175-30181.
26. Horkko, S., D. A. Bird, E. Miller, H. Itabe, N. Leitinger, G. Subbanagounder, J. A. Berliner, P. Friedman, E. A. Dennis, L. K. Curtiss, et al. 1999. Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. J. Clin. Invest. 103: 117-128.
27. Gargalovic, P. S., N. M. Gharavi, M. J. Clark, J. Pagnon, W-P. Yang, A. He, A. Truong, T. Baruch-Oren, J. A. Berliner, T. G. Kirchgessner, et al. 2006. The unfolded protein response is an important regulator of inflammatory genes in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 26: 2490-2496.
28. Back, M., and G. K. Hansson. 2006. Leukotriene receptors in atherosclerosis. Ann. Med. 38: 493-502.
29. Chiang, N., C. N. Serhan, S-E. Dahlen, J. M. Drazen, D. W. P. Hay, G. E. Rovati, T. Shimizu, T. Yokomizo, and C. Brink. 2006. The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo. Pharmacol. Rev. 58: 463-487.
30. Pegorier, S., D. Stengel, H. Durand, M. Croset, and E. Ninio. 2006. Oxidized phospholipid: POVPC binds to platelet-activating-factor receptor on human macrophages. Implications in atherosclerosis. Atherosclerosis. 188: 433-443.
31. Hwang, S. B. 1990. Specific receptors of platelet-activating factor, receptor heterogeneity, and signal transduction mechanisms. J. Lipid Mediat. 2: 123-158.
32. Chalfant, C. E., and S. Spiegel. 2005. Sphingosine 1-phosphate and ceramide 1-phosphate: expanding roles in cell signaling. J. Cell Sci. 118: 4605-4612.
33. Zhu, T., F. Gobeil, A. Vazquez-Tello, M. Leduc, L. Rihakova, M. Bossolasco, G. Bkaily, K. Peri, D. R. Varma, R. Orvoine, et al. 2006. Intracrine signaling through lipid mediators and their cognate nuclear G-protein-coupled receptors: a paradigm based on PGE2, PAF, and LPA1 receptors. Can. J. Physiol. Pharmacol. 84: 377-391.
34. Li, R., K. P. Mouillesseaux, D. Montoya, D. Cruz, N. Gharavi, M. Dun, L. Koroniak, and J. A. Berliner. 2006. Identification of prostaglandin E2 receptor subtype 2 as a receptor activated by OxPAPC. Circ. Res. 98: 642-650.
35. Navab, M., G. P. Hough, L. W. Stevenson, D. C. Drinkwater, H. Laks, and A. M. Fogelman. 1988. Monocyte migration into the subendothelial space of a coculture of adult human aortic endothelial and smooth muscle cells. J. Clin. Invest. 82: 1853-1863.
36. Yeh, M., A. L. Cole, J. Choi, Y. Liu, D. Tulchinsky, J. H. Qiao, M. C. Fishbein, A. N. Dooley, T. Hovnanian, K. Mouilleseaux, et al. 2004. Role for sterol regulatory element-binding protein in activation of endothelial cells by phospholipid oxidation products. Circ. Res. 95: 780-788.
37. Gargalovic, P. S., M. Imura, B. Zhang, N. M. Gharavi, M. J. Clark, J. Pagnon, W-P. Yang, A. He, A. Truong, S. Patel, et al. 2006. Identification of inflammatory gene modules based on variations of human endothelial cell responses to oxidized lipids. Proc. Natl. Acad. Sci. USA. 103: 12741-12746.
38. Yeh, M., N. Leitinger, R. de Martin, N. Onai, K. Matsushima, D. K. Vora, J. A. Berliner, and S. T. Reddy. 2001. Increased transcription of IL-8 in endothelial cells is differentially regulated by TNF-{alpha} and oxidized phospholipids. Arterioscler. Thromb. Vasc. Biol. 21: 1585-1591.
39. Salomon, R. G. 2005. Isolevuglandins, oxidatively truncated phospholipids, and atherosclerosis. Ann. N. Y. Acad. Sci. 1043: 327-342.
40. Schweizer, A., J. Rohrer, P. Jeno, A. DeMaio, T. G. Buchman, and H. P. Hauri. 1993. A reversibly palmitoylated resident protein (p63) of an ER-Golgi intermediate compartment is related to a circulatory shock resuscitation protein. J. Cell Sci. 104: 685-694.
41. Razzaq, T. M., R. Bass, D. J. Vines, F. Werner, S. A. Whawell, and V. Ellis. 2003. Functional regulation of tissue plasminogen activator on the surface of vascular smooth muscle cells by the type-II transmembrane protein p63 (CKAP4). J. Biol. Chem. 278: 42679-42685.
42. Waugh, R. J., J. D. Morrow, L. J. Roberts, II, and R. C. Murphy. 1997. Identification and relative quantitation of F2-isoprostane regioisomers formed in vivo in the rat. Free Radic. Biol. Med. 23: 943-954.
43. Tallman, K. A., H. Y. H. Kim, J. X. Ji, M. E. Szapacs, H. Yin, T. J. McIntosh, D. C. Liebler, and N. A. Porter. 2007. Phospholipid-protein adducts of lipid peroxidation: synthesis and study of new biotinylated phosphatidylcholines. Chem. Res. Toxicol. 20: 227-234.
44. Boullier, A., P. Friedman, R. Harkewicz, K. Hartvigsen, S. R. Green, F. Almazan, E. A. Dennis, D. Steinberg, J. L. Witztum, and O. Quehenberger. 2005. Phosphocholine as a pattern recognition ligand for CD36. J. Lipid Res. 46: 969-976.
45. Cech, N. B., J. R. Krone, and C. G. Enke. 2001. Electrospray ionization detection of inherently nonresponsive epoxides by peptide binding. Rapid Commun. Mass Spectrom. 15: 1040-1044.
46. Jayaraj, K., N. I. Georgieva, A. Gold, R. Sangaiah, H. Koc, D. G. Klapper, L. M. Ball, A. P. Reddy, and J. A. Swenberg. 2003. Synthesis and characterization of peptides containing a cyclic Val adduct of diepoxybutane, a possible biomarker of human exposure to butadiene. Chem. Res. Toxicol. 16: 637-643.
47. Leitinger, N., T. R. Tyner, L. Oslund, C. Rizza, G. Subbanagounder, H. Lee, P. T. Shih, N. Mackman, G. Tigyi, M. C. Territo, et al. 1999. Structurally similar oxidized phospholipids differentially regulate endothelial binding of monocytes and neutrophils. Proc. Natl. Acad. Sci. USA. 96: 12010-12015.